Rapamycin is widely considered the leading drug candidate for slowing aging — but a new study suggests it may undercut the health gains from physical exercise in older adults.
Thousands of people already take rapamycin — a transplant drug — hoping it will slow their aging. For years, the evidence behind that idea was almost entirely from mice.